Company News
Sudarshan Pharma Targets 9.5% MedTherapy Stake
Sudarshan Pharma Industries Ltd board approved acquisition of a 9.5% equity stake in US‑based MedTherapy Biotechnology Inc.
Promoters Hemal Mehta and Sachin Mehta each propose buying 1.5% of MedTherap
